12441803

Source:http://linkedlifedata.com/resource/pubmed/id/12441803

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0033522, umls-concept:C0033607, umls-concept:C0034656, umls-concept:C0150369, umls-concept:C0220825, umls-concept:C0302350, umls-concept:C0439230, umls-concept:C0814225, umls-concept:C1274040
pubmed:dateCreated	2002-11-20
pubmed:abstractText	A randomized study to evaluate the usefulness of protease inhibitor (PI) therapeutic drug monitoring (TDM) in antiretroviral-experienced HIV-infected patients.
pubmed:language	eng
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral
pubmed:status	MEDLINE
pubmed:author	pubmed-author:ClevenberghPhilippeP, pubmed-author:DellamonicaPierreP, pubmed-author:DurantJacquesJ, pubmed-author:GarraffoRodolpheR
pubmed:copyrightInfo	Copyright 2002 Lippincott Williams & Wilkins
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2311-5
pubmed:dateRevised	2006-11-15
pubmed:articleTitle	PharmAdapt: a randomized prospective study to evaluate the benefit of therapeutic monitoring of protease inhibitors: 12 week results.
pubmed:affiliation	Infectious Diseases Department, CHU Nice, Nice, France. clevenberghph@hotmail.com